Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (161-170 of 8,369) with videos related to

Pageof 837
Sort By:
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Drugs|April 12, 2022
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma TherapyBarry Paul, Cesar Rodriguez, Saad Z Usmani
Drugs|April 12, 2022
Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung CancerManan P Shah, Joel W Neal
Drugs|June 19, 2017
Abaloparatide: First Global ApprovalMatt Shirley
Drugs|June 22, 2017
Erratum to: Zidovudine: An Update of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic EfficacyMichelle I Wilde, Heather D Langtry
Drugs|September 23, 2016
Apixaban: A Review in Venous ThromboembolismSarah L Greig, Karly P Garnock-Jones
Drugs|January 1, 1988
In vitro studies on the mode of action of pinacidilA H Weston, K M Bray, S Duty, et al.
Drugs|June 9, 2017
Erdosteine : A Viewpoint by Margaret WilsherMargaret Wilsher
Drugs|June 9, 2017
Quinupristin-Dalfopristin A Viewpoint : A Viewpoint by Roland LeclercqRoland Leclercq
Drugs|June 9, 2017
Remifentanil : A Viewpoint by Peter S.A. GlassPeter S A Glass
Pageof 837

Showing results (161-170 of 8,369) with videos related to

Sort By:
Pageof 837
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Drugs|April 12, 2022
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma TherapyBarry Paul, Cesar Rodriguez, Saad Z Usmani
Drugs|April 12, 2022
Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung CancerManan P Shah, Joel W Neal
Drugs|June 19, 2017
Abaloparatide: First Global ApprovalMatt Shirley
Drugs|June 22, 2017
Erratum to: Zidovudine: An Update of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic EfficacyMichelle I Wilde, Heather D Langtry
Drugs|September 23, 2016
Apixaban: A Review in Venous ThromboembolismSarah L Greig, Karly P Garnock-Jones
Drugs|January 1, 1988
In vitro studies on the mode of action of pinacidilA H Weston, K M Bray, S Duty, et al.
Drugs|June 9, 2017
Erdosteine : A Viewpoint by Margaret WilsherMargaret Wilsher
Drugs|June 9, 2017
Quinupristin-Dalfopristin A Viewpoint : A Viewpoint by Roland LeclercqRoland Leclercq
Drugs|June 9, 2017
Remifentanil : A Viewpoint by Peter S.A. GlassPeter S A Glass
Pageof 837